Culinary spice bioactives as potential therapeutics against SARS-CoV-2: Computational investigation.
Jagadish, N. and Priya, Mondal and Dhanamjai, Penta and Abdul Ajees, Abdul Salam and Meeran, Syed Musthapa (2021) Culinary spice bioactives as potential therapeutics against SARS-CoV-2: Computational investigation. Computers in Biology and Medicine, 128. p. 104102.
| ![Computers in Biology and Medicine 128 (2021) 104102.pdf [thumbnail of Computers in Biology and Medicine 128 (2021) 104102.pdf]](http://ir.cftri.res.in/style/images/fileicons/other.png) | PDF Computers in Biology and Medicine 128 (2021) 104102.pdf - Published Version Restricted to Registered users only Download (12MB) | Request a copy | 
Abstract
Background: Coronavirus disease-2019 (COVID-19) is an infectious pandemic caused by SARS-CoV-2. SARS-CoV2 main protease (Mpro) and spike protein are crucial for viral replication and transmission. Spike protein recognizes the human ACE2 receptor and transmits SARS-CoV-2 into the human body. Thus, Mpro, spike protein, and ACE2 receptor act as appropriate targets for the development of therapeutics against SARS-CoV-2. Spices are traditionally known to have anti-viral and immune-boosting activities. Therefore, we investigated the possible use of selected spice bioactives against the potential targets of SARS-CoV-2 using computational analysis. Methods: Molecular docking analysis was performed to analyze the binding efficiency of spice bioactives against SARS-CoV-2 target proteins along with the standard drugs. Drug-likeness properties of selected spice bioactives were investigated using Lipinski’s rule of five and the SWISSADME database. Pharmacological properties such as ADME/T, biological functions, and toxicity were analyzed using ADMETlab, PASS-prediction, and ProTox-II servers, respectively. Results: Out of forty-six spice bioactives screened, six bioactives have shown relatively better binding energies than the standard drugs and have a higher binding affinity with at least more than two targets of SARS-CoV-2. The selected bioactives were analyzed for their binding similarities with the standard drug, remdesivir, towards the targets of SARS-CoV-2. Selected spice bioactives have shown potential drug-likeness properties, with higher GI absorption rate, lower toxicity with pleiotropic biological roles. Conclusions: Spice bioactives have the potential to bind with the specific targets involved in SARS-CoV-2 infection and transmission. Therefore, spice-based nutraceuticals can be developed for the prevention and treatment of COVID-19.
| Item Type: | Article | 
|---|---|
| Uncontrolled Keywords: | Drug-likeness Molecular docking Nutraceuticals SARS-CoV-2 Spice | 
| Subjects: | 600 Technology > 08 Food technology > 18 Processed foods > 04 Functional foods 600 Technology > 08 Food technology > 30 Spices/Condiments | 
| Divisions: | Dept. of Biochemistry | 
| Depositing User: | Food Sci. & Technol. Information Services | 
| Date Deposited: | 04 Dec 2020 05:48 | 
| Last Modified: | 04 Dec 2020 05:48 | 
| URI: | http://ir.cftri.res.in/id/eprint/14686 | 
Actions (login required)
|  | View Item | 
 
	
![[feed]](/style/images/feed-icon-14x14.png)